screening guidelines and treatment
Advancing the Care of Lung Cancer
Zach Reagle, MD, warns that lung cancer should be of concern to everybody. A snapshot of people with lung cancer reveals: 20.9% current smokers, 60% former smokers and 17.9% never smoked. It takes about 300 lung screenings of high risk individuals to detect one lung cancer while it takes about 750-800 mammograms to detect a breast cancer. That makes it even more effective than a test that is well accepted and has been in use for many years. Lung cancer still kills more people than any other cancer. Though work is being done to find better methods of testing, not just for high-risk (being that 10-15% of those diagnosed never smoked), by the evidence, this is the best screening tool we have now for lung cancer. For those who still smoke, quitting smoking is the best way to reduce their risk of developing lung cancer—hands down—and everything should be done to support smokers who want to quit.
Kathi Downey is an advocate to raise awareness for lung cancer—especially for non-smokers. Her sister was diagnosed with incurable Stage 3B Lung Cancer. As she was a non-smoker, this diagnosis was truly a shock. Kathi will share her experience and emphasize six important symptoms to look for as an early warning sign for non-smokers:
— A cough that lasts longer than three weeks, or any cough with blood
—Losing weight without trying
—Shortness of breath, wheezing, hoarseness
—Persistent chest, back or shoulder pain
—Unusual, ongoing fatigue
— Recurring respiratory infections; i.e., colds, bronchitis, pneumonia
Carol Lowe, RN, OCN, lung cancer nurse navigator, will be available to assist participants in determining candidacy for the screening program. Don’t miss this important event!
Marian Regional Medical Center is the first in the area to provide the superDimension® i·Logic™ System as an option for patients who have a hard-to-reach lesion on their lung. A minimally-invasive procedure called Electromagnetic Navigation Bronchoscopy (ENB) combines GPS-like technology with a catheter-based system that uses the patient’s natural airways to access lesions that were previously hard to reach. A patient with a spot on their lung used to have the difficult options of major surgery to remove a section of the lung, bronchoscopy (which does not reach lesions deep in the lung), needle biopsy, or watchful waiting. This new procedure starts where the bronchoscope ends, enabling physicians to navigate to the boundaries of the lungs to locate, enable biopsy, and plan treatment using natural airway access avoiding the need for higher-risk procedures. This procedure provides safe and efficient access to stage and prepare to treat lung lesions even in non-operable patients.